Disease | liver disease |
Phenotype | |portal hypertension |
Sentences | 56 |
PubMedID- 25374709 | Hepatic myelopathy or porto-systemic myelopathy is a rare neurological complication of chronic liver disease with portal hypertension, usually associated with porto-systemic shunting, and presents as pure motor spastic paraparesis without sensory or sphincter involvement. |
PubMedID- 21055685 | Hepatic granulomas may be manifested clinically by elevated levels of serum alkaline phosphatase and g-glutamyltransferase enzymes, damage to specific structures (eg, intrahepatic bile ducts in primary biliary cirrhosis), or infrequently, progressive liver disease with portal hypertension and cirrhosis (eg, sarcoidosis). |
PubMedID- 21685145 | Background: a group of non-cirrhotic chronic liver diseases, all with sustained portal hypertension and clinically mistaken as cirrhosis, have been described under various names, apparently because of differences in pathological features. |
PubMedID- 22190914 | Reported that the accuracy of their string ece for diagnosing ev and portal hypertension in patients with chronic liver disease was excellent [23]. |
PubMedID- 22586877 | She also had diagnoses of chronic liver disease with cirrhotic changes, portal hypertension, and grade iv manageesophageal varices with hepatosplenomegaly. |
PubMedID- 24782928 | Dyspnea in a patient with liver dysfunction usually makes one suspects hepatopulmonary syndrome, portopulmonary hypertension, cardiomyopathy, hepatic hydrothorax, ascites, or anemia, whereas ascites itself is a hallmark of liver disease complicated by portal hypertension. |
Page: 1 2